Bupropion-Related Exacerbation of Tic Disorder in an Adult: A Case Report.

Abstract	Bupropion is antidepressant and a smoking cessation aid medication related to dopaminergic activity. We report for the first time a case of an older adult with a known tic disorder, which was in remission but exacerbated during treatment with bupropion. It has been reported that other dopaminergic compounds such as methylphenidate can exacerbate tic disorder. Clinicians should be aware of this potential adverse effect when prescribing bupropion to adults with tic and other motor disorders.
Authors	Ido Lurie, Ori Ganor, Gad Mayer
Journal	Clinical neuropharmacology (Clin Neuropharmacol) 2019 Jan/Feb Vol. 42 Issue 1 Pg. 19 ISSN: 1537-162X [Electronic] United States
PMID	30499776 (Publication Type: Case Reports, Journal Article)
Chemical References	Antidepressive Agents, Second-Generation Delayed-Action Preparations Bupropion
Topics	Aged Antidepressive Agents, Second-Generation (administration & dosage, adverse effects) Bupropion (administration & dosage, adverse effects) Delayed-Action Preparations Humans Male Tic Disorders (chemically induced)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!